#Antibody

Eugene Gu, MD

eugenegu

I’ve warned about this many times, but it always fell on deaf ears as everyone likes rushing things through clinical trials and doing emergency authorizations at warp speed. Convalescent plasma

Scott Beasley

SkyScottBeasley

Early trial data of AstraZeneca vaccine shows limited efficacy against mile disease due to the South Africa variant BUT they don’t know yet if that means it will also be

Yinon Weiss

yinonw

This is not to say that only 15-20% were exposed to covid. It says only 15-20% express antibodies, because many are able to kill coronaivrus before their body even needs

Mac n’ Chise 🧬🧫🦠

sailorrooscout

More promising mRNA vaccine data! This time from Moderna. A new Phase II study shows that half-doses (50 μg) of our vaccine appear to be as effective as full doses

Michael Kronenberg

SubBasepair_Res

Interesting Merck valued VelosBio's ROR1-based antibody technology at 2.75 billion with only preclinical data available. VelosBio's VLS-101 is an antibody carrying a spindle poison payload, which is toxic to all

John Bye

_johnbye

The government recently admitted its labs are struggling to meet demand, forcing them to ration access to testing to reduce delays and voided tests.Headline capacity figures look like they have

facts&effects

EffectsFacts

(1/9) Week 27 update. Retroactive revisions of deaths in week 26 but the trend remains intact. After 6 weeks since reported cases surged there is still a consistent decline in

Edwin Hayward 🦄 🗡

uk_domain_names

"Hancock has also announced today that the government has secured 20m lateral flow tests from a contract with the Derby-based manufacturer SureScreen Diagnostics."Is there a Tory connection? Would be weird

CADDE Project

CaddeProject

Here is a thread to accompany our work published today in @ScienceMagazine (https://science.sciencemag.org/content/early/2020/12/07/science.abe9728), comparing SARS-CoV-2 IgG antibody prevalence in Manaus and São Paulo. @FAPESP @The_MRC @I

Jon Deeks

deeksj

BBC News - Coronavirus antibodies tests 'put public at risk' https://www.bbc.co.uk/news/health-53853967Our review of websales of COVID-19 antibody tests reported after @BBCNewsnight with @deb_cohen @charliehtweets last night. Joint

Brian Hjelle, virologist

hjelle_brian

This virologist has never been more impressed by a bug's ability to quash our innate immune response than by SARS-CoV-2. Now he is starting to think virus is after our

Dr. Lynora Saxinger 🇨🇦

AntibioticDoc

I can see why this seems odd but: available data suggests that once vaccinated, YOU are likely protected from severe COVID VERY quickly, from symptomatic COVID19 at all by the

Peaceful Warrior

Peaceful4812

Well, well, well what do we have here https://dominiondiagnostics.com/covid-19-total-antibody-serology-testing Dominon is also connected to the antibody testing eh! I Am going to go out on a limb here and

Florian Krammer

florian_krammer

1) If we want to generate difficult viral escape mutants in the lab (e.g. for epitope mapping), we subject the virus to low antibody pressure and then slowly move up.

Bloom Lab

jbloom_lab

Our study mapping #SARSCoV2 mutations that escape key therapeutic monoclonal antibodies is out in @ScienceMagazine. The study also shows that some of these escape mutations arise in a persistently infected

Sandy Macdonald

sandyjmacdonald

The hypothesis that this new variant came about after months of replication and selective pressure in an immunocomprised patient is fascinating for a number of reasons. First, it must have

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.